Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureKouta Niizuma, Alyssa H Chang, Yoshia Okamoto, Jeewon Kim, Stéphan Busque, Ravindra Majeti, Hiromitsu Nakauchi, Yusuke Nakauchi
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Steroid refractory acute GVHD: the hope for a better tomorrow
10.1002/ajh.27592 · 2025
Lessons learned from early closure of a clinical trial for steroid-refractory acute GVHD
10.1038/s41409-021-01529-x · 2022
Novel developments in the prophylaxis and treatment of acute GVHD
10.1182/blood.2023020073 · 2023
Acute graft-versus-host disease
10.1038/s41572-023-00438-1 · 2023
Graft-versus-host disease following liver transplantation: a systematic review of literature
10.1097/hc9.0000000000000260 · 2023
How I diagnose and treat acute graft-versus-host disease after solid organ transplantation
10.1182/blood.2022015954 · 2023
Selective depletion of naive T cells by targeting CD45RA
10.3389/fonc.2022.1009143 · 2022
Post-transplant cyclophosphamide–based graft-versus-host disease prophylaxis attenuates disparity in outcomes between use of matched or mismatched unrelated donors
10.1200/jco.24.00184 · 2024
A single dose of a CD137 antibody-drug conjugate protects rhesus macaque allogeneic HCT recipients against acute GVHD
10.1182/blood.2024027239 · 2025
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
datacite
Confidence 0%
Effective treatment against severe graft-versus-host disease with allele-specific anti-HLA monoclonal antibody in a humanized mouse model
10.1016/j.exphem.2014.10.008 · 2015
Donor-targeted serotherapy as a rescue therapy for steroid-resistant acute GVHD after HLA-mismatched kidney transplantation
10.1111/ajt.15827 · 2020
A rapid and efficient strategy to generate allele-specific anti-HLA monoclonal antibodies
10.1016/j.jim.2009.01.007 · 2009
Structural basis for the differential classification of HLA-A6802 and HLA-A6801 into the A2 and A3 supertypes
10.1016/j.molimm.2013.03.015 · 2013
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy
10.1038/s41590-017-0004-z · 2018
Xenogeneic graft-versus-host disease in NOD-scid IL-2Rγnull mice displays a T-effector memory phenotype
10.1371/journal.pone.0044219 · 2012
Cytotoxic T-cell responses in HLA-A2.1 transgenic mice: recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element
10.4049/jimmunol.142.4.1366 · 1989
HLA and proteasome expression body map
10.1186/s12920-018-0354-x · 2018
IFN-α activates dormant haematopoietic stem cells in vivo
10.1038/nature07815 · 2009
Targeting leukemia stem cells in the bone marrow niche
10.3390/biomedicines6010022 · 2018
Analysis of the frequencies of HLA-A, B, and C alleles and haplotypes in the five major ethnic groups of the United States reveals high levels of diversity in these loci and contrasting distribution patterns in these populations
10.1016/s0198-8859(01)00298-1 · 2001
Six-locus high-resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry
10.1016/j.humimm.2013.06.025 · 2013
No additional external references are available.